Relapsed Pediatric Acute Myeloid Leukemia
Beyond CD19: Opportunities for Future Development of Targeted Immunotherapy in Pediatric Relapsed-Refractory Acute Leukemia.
13
Gemtuzumab ozogamicin in children with relapsed or refractory acute myeloid leukemia: a report by Berlin-Frankfurt-Münster study group
10
MicroRNA biomarker identification for pediatric acute myeloid leukemia based on a novel bioinformatics model
13
Acute Myeloid Leukemia in Pediatric Patients: A Review About Current Diagnostic and Treatment Approaches
23
Oncologist. The. Pediatric Oncology. Prognostic Factors and Risk-Based Therapy in Pediatric Acute Myeloid Leukemia
15
MicroRNA-106b~25 cluster is upregulated in relapsed MLL-rearranged pediatric acute myeloid leukemia
11
Anti-cancer effects of ginsenoside compound k on pediatric acute myeloid leukemia cells
6
Acute Myeloid Leukemia
52
Analysis of BAALC gene Expression as prognosis factor in Pediatric Acute Myeloid Leukemia in Iran
8
The prevalent predicament of relapsed acute myeloid leukemia
6
Upregulation of microRNA-100 predicts poor prognosis in patients with pediatric acute myeloid leukemia
7
Temozolomide and cisplatin in relapsed/refractory acute leukemia
6
Dose-related efficacy and toxicity of gemtuzumab ozogamicin in pediatric acute myeloid leukemia
11
The hypomethylating agent decitabine prior to chemotherapy improves the therapy efficacy in refractory/relapsed acute myeloid leukemia patients
11
MOLECULAR ASPECTS OF ACUTE MYELOID LEUKEMIA
6
Novel agents for acute myeloid leukemia
18
The epigenetic landscape of acute myeloid leukemia
16
Acute Myeloid Leukemia Research Paper
11
Cytarabine Dose for Acute Myeloid Leukemia
10
Perspectives on the Treatment of Acute Myeloid Leukemia
14